Expansion momentum Pegasus Laboratories is actively expanding its Pensacola facility and headcount, signaling growing production capacity and potential for broader contract manufacturing opportunities in animal health and nutraceuticals.

Leadership growth Recent appointment of a new VP of Sales and Commercial Operations suggests a strategic emphasis on scaling commercial efforts, channel development, and customer acquisition in the veterinary and animal health markets.

Acquisition activity The acquisition of TriviumVet and ongoing Liavium-CA1 clinical program indicate expanded product portfolios and ongoing clinical development capabilities that can be leveraged for co-development, technology licensing, or white-label partnerships.

Integrated CDMO strengths As a full-service cGMP and DEA-approved contractor with in-house development, formulation, method development, and site transfer, Pegasus offers end-to-end outsourcing advantages for veterinary pharma customers seeking turnkey solutions.

Partnership readiness With an employee-owned culture, established quality focus, and recent facility growth, Pegasus presents a compelling value proposition for strategic collaborations, private-label arrangements, and long-term contract manufacturing commitments.